- Home
- CDTX vs CGBD Comparison
CDTX vs CGBD Comparison
Compare CDTX & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- CGBD
- Stock Information
- Founded
- CDTX 2012
- CGBD 2012
- Country
- CDTX United States
- CGBD United States
- Employees
- CDTX N/A
- CGBD N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- CGBD Finance: Consumer Services
- Sector
- CDTX Health Care
- CGBD Finance
- Exchange
- CDTX Nasdaq
- CGBD Nasdaq
- Market Cap
- CDTX 980.1M
- CGBD 1.0B
- IPO Year
- CDTX 2015
- CGBD 2017
- Fundamental
- Price
- CDTX $63.31
- CGBD $13.79
- Analyst Decision
- CDTX Strong Buy
- CGBD Hold
- Analyst Count
- CDTX 11
- CGBD 4
- Target Price
- CDTX $52.11
- CGBD $14.67
- AVG Volume (30 Days)
- CDTX 659.9K
- CGBD 400.9K
- Earning Date
- CDTX 08-07-2025
- CGBD 08-05-2025
- Dividend Yield
- CDTX N/A
- CGBD 13.35%
- EPS Growth
- CDTX N/A
- CGBD N/A
- EPS
- CDTX N/A
- CGBD 1.30
- Revenue
- CDTX $302,000.00
- CGBD $225,447,000.00
- Revenue This Year
- CDTX N/A
- CGBD $14.27
- Revenue Next Year
- CDTX N/A
- CGBD $5.97
- P/E Ratio
- CDTX N/A
- CGBD $10.60
- Revenue Growth
- CDTX N/A
- CGBD N/A
- 52 Week Low
- CDTX $10.14
- CGBD $13.12
- 52 Week High
- CDTX $66.95
- CGBD $18.64
- Technical
- Relative Strength Index (RSI)
- CDTX 70.66
- CGBD 44.02
- Support Level
- CDTX $60.71
- CGBD $13.85
- Resistance Level
- CDTX $66.95
- CGBD $14.25
- Average True Range (ATR)
- CDTX 4.25
- CGBD 0.25
- MACD
- CDTX -0.39
- CGBD -0.01
- Stochastic Oscillator
- CDTX 79.25
- CGBD 5.36
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.